URGN UroGen Pharma Ltd.
UroGen Pharma Ltd. (URGN) Institutional Ownership
What the institutions did with URGN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| RTW INVESTMENTS, LP | 4.5M | 10.7% |
| BlackRock, Inc. | 3.2M | 7.6% |
| MORGAN STANLEY | 2.6M | 6.1% |
| Kynam Capital Management, LP | 2.4M | 5.7% |
| Jefferies Financial Group Inc. | 2.2M | 5.2% |
| SG Americas Securities, LLC | 2.1M | 4.8% |
| AMERICAN CENTURY COMPANIES INC | 1.7M | 4.0% |
| ACORN CAPITAL ADVISORS, LLC | 1.7M | 3.9% |
| Point72 Asset Management, L.P. | 1.5M | 3.6% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.5M | 3.6% |
| Opaleye Management Inc. | 1.4M | 3.4% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.3M | 3.1% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1.2M | 2.7% |
| D. E. Shaw & Co., Inc. | 1.1M | 2.7% |
| STATE STREET CORP | 1.0M | 2.4% |
| MPM BIOIMPACT LLC | 933.4K | 2.2% |
| Soleus Capital Management, L.P. | 829.8K | 2.0% |
| GOLDMAN SACHS GROUP INC | 819.8K | 1.9% |
| Migdal Insurance & Financial Holdings Ltd. | 770.9K | 1.8% |
| ORBIMED ADVISORS LLC | 676.2K | 1.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 610.4K | 1.4% |
| Woodline Partners LP | 500.7K | 1.2% |
| Boxer Capital Management, LLC | 500.0K | 1.2% |
| BANK OF AMERICA CORP /DE/ | 475.7K | 1.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 456.6K | 1.1% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| TORONTO DOMINION BANK | Sold Out | 2.6M | 0 | -2.6M |
| Paradigm Biocapital Advisors LP | Sold Out | 1.7M | 0 | -1.7M |
| Point72 Asset Management, L.P. | New | 0 | 1.5M | +1.5M |
| J. Goldman & Co LP | Reduced | 938.9K | 212.8K | -726.1K |
| TCG Crossover Management, LLC | Sold Out | 405.4K | 0 | -405.4K |
| SG Americas Securities, LLC | Increased | 1.7M | 2.1M | +395.1K |
| BlackRock, Inc. | Increased | 2.8M | 3.2M | +355.9K |
| TANG CAPITAL MANAGEMENT LLC | Sold Out | 350.0K | 0 | -350.0K |
| BANK OF AMERICA CORP /DE/ | Increased | 126.8K | 475.7K | +348.9K |
| MILLENNIUM MANAGEMENT LLC | Reduced | 370.9K | 106.7K | -264.2K |
| CITADEL ADVISORS LLC | Reduced | 268.0K | 13.0K | -255.0K |
| GOLDMAN SACHS GROUP INC | Increased | 598.5K | 819.8K | +221.3K |
| SILVERARC CAPITAL MANAGEMENT, LLC | Reduced | 1.5M | 1.3M | -201.1K |
| ORBIMED ADVISORS LLC | Reduced | 875.5K | 676.2K | -199.3K |
| SUPERSTRING CAPITAL MANAGEMENT LP | Reduced | 387.4K | 191.3K | -196.1K |
| FRONTIER CAPITAL MANAGEMENT CO LLC | Increased | 1.3M | 1.5M | +194.4K |
| Kynam Capital Management, LP | Increased | 2.2M | 2.4M | +186.8K |
| DEUTSCHE BANK AG\ | Reduced | 236.2K | 51.6K | -184.6K |
| ADAR1 Capital Management, LLC | Reduced | 395.5K | 252.4K | -143.1K |
| Vestal Point Capital, LP | Sold Out | 139.1K | 0 | -139.1K |
| Ally Bridge Group (NY) LLC | Reduced | 202.1K | 69.2K | -132.9K |
| STATE STREET CORP | Increased | 874.2K | 1.0M | +128.9K |
| Schonfeld Strategic Advisors LLC | Reduced | 158.1K | 32.5K | -125.7K |
| D. E. Shaw & Co., Inc. | Increased | 1.0M | 1.1M | +122.7K |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | Reduced | 230.6K | 111.1K | -119.5K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.